Norris Medicines Fair Value
Norris Medicines (NORRIS) average fair value is ₹29.88 across 1 valuation models — Price-to-Sales Valuation, vs a current market price of ₹12.76 (+134.17%), fair value range ₹29.88–₹29.88. Also explore NORRIS stock price history to track price trends across different timeframes.
Fair Value Analysis Export
NORRIS Fair Value vs Current Price — Valuation Summary
NORRIS average fair value, fair value range, price gap and valuation status across 1 models: Price-to-Sales Valuation. See NORRIS price to book ratio to compare market price against book value per share.
Price-to-Sales Valuation
NORRIS Fair Value Analysis — Data Sources & Coverage
Norris Medicines financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit NORRIS stock price BSE.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
NORRIS vs Commercial Services Sector Peers — P/E, P/B & Market Cap
Norris Medicines P/E ratio, P/B ratio and market capitalisation vs Commercial Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Quasar | QUASAR | - | 0.14 | ₹14 |
| Viksit Engineering | VIKSHEN | - | - | - |
| Sarthak Global | SARTHAKGL | 22.19 | 5.34 | ₹11 |
| Maximus International | MAXIMUS | 14.93 | 1.72 | ₹136 |
| Real Growth Corporation | RGCORP | - | - | - |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.